U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
179011179011Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty AcidsTerminatedNo Results AvailableSchizophreniaDrug: Olanzapine, Omega 3, Vitamin E+Chttps://ClinicalTrials.gov/show/NCT00211562
179012179012An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the KneeCompletedNo Results AvailableOsteoarthritis, KneeDrug: IDEA-033https://ClinicalTrials.gov/show/NCT00211549
179013179013Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin AdministrationCompletedHas ResultsType 1 DiabetesDrug: Medtronic MiniMed Implantable Pump Human Recombinant Insulin|Device: Medtronic MiniMed Implantable Pump System|Drug: Aventis HOE21PH U400https://ClinicalTrials.gov/show/NCT00211536
179014179014Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of AcneCompletedNo Results AvailableAcne Vulgaris|Acne|Propionibacterium AcnesDrug: MBI 226 Acne Solutionshttps://ClinicalTrials.gov/show/NCT00211523
179015179015Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 DiabetesCompletedHas ResultsType 1 DiabetesDevice: Paradigm 722 Sensor-augmented pump|Device: Paradigm 715 insulin pumphttps://ClinicalTrials.gov/show/NCT00211510
179016179016Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of AcneCompletedNo Results AvailableAcne Vulgaris|Acne|Propionibacterium AcnesDrug: MBI 226 Acne Solutionshttps://ClinicalTrials.gov/show/NCT00211497
179017179017Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.CompletedNo Results AvailableAge-Related Macular Degenerations.|Subfoveal Neovascularization.Drug: Anecortave Acetatehttps://ClinicalTrials.gov/show/NCT00211484
179018179018Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).TerminatedNo Results AvailableSevere Diabetic Retinopathy|Central Retinal Vein Occlusion|Chronic Inflammation|Infectious DiseasesDrug: anecortave acetatehttps://ClinicalTrials.gov/show/NCT00211471
179019179019Treatment of Age-Related Macular Degeneration With Anecortave AcetateCompletedNo Results AvailableMacular DegenerationDrug: Anecortave Acetate Sterile Suspension (15 mg)https://ClinicalTrials.gov/show/NCT00211458
179020179020Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)CompletedNo Results AvailableChronic Central Serous ChorioretinopathyProcedure: Photodynamic Therapy with Verteporfin|Drug: verteporfin|Drug: Verteporfinhttps://ClinicalTrials.gov/show/NCT00211445
179021179021Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)CompletedNo Results AvailablePseudovitellium Detachment|Eye DiseasesDrug: Anecortave Acetate Sterile Suspension (15 mg)https://ClinicalTrials.gov/show/NCT00211432
179022179022Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)CompletedNo Results AvailableMaculopathy, Age-RelatedDrug: Anecortave Acetate 15 mg|Drug: Triamcinolone Acetate 4 mg|Procedure: Photodynamic Therapy with Verteporfin|Procedure: Thermal Laserhttps://ClinicalTrials.gov/show/NCT00211419
179023179023Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)TerminatedNo Results AvailableDiabetic RetinopathyDrug: Anecortave Acetate Sterile Suspension (15 mg)https://ClinicalTrials.gov/show/NCT00211406
179024179024A Pilot Study of the Treatment of Central Serous Chorioretinopathy With KetoconazoleCompletedNo Results AvailableChronic Central Serous ChorioretinopathyDrug: ketoconazolehttps://ClinicalTrials.gov/show/NCT00211393
179025179025Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)TerminatedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: aripiprazolehttps://ClinicalTrials.gov/show/NCT00211380
179026179026Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)TerminatedNo Results AvailableEye InjuriesDrug: Anecortave Acetatehttps://ClinicalTrials.gov/show/NCT00211367
179027179027Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)WithdrawnNo Results AvailableRetinal Vein OcclusionDrug: Anecortave Acetatehttps://ClinicalTrials.gov/show/NCT00211354
179028179028Trial of the Impact of Vitamin A on Maternal MortalityCompletedNo Results AvailableVitamin A Deficiency|Maternal Mortality|Maternal MorbidityDietary Supplement: Vitamin Ahttps://ClinicalTrials.gov/show/NCT00211341
179029179029Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).CompletedNo Results AvailableIdiopathic Perifoveal TelangiectasiaDrug: anecortave acetatehttps://ClinicalTrials.gov/show/NCT00211328
179030179030Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)CompletedNo Results AvailableCoat's DiseaseDrug: anecortave acetatehttps://ClinicalTrials.gov/show/NCT00211315
179031179031Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)TerminatedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: aripiprazolehttps://ClinicalTrials.gov/show/NCT00211302
179032179032Trial of Education and Compliance in Heart Dysfunction (TEACH)RecruitingNo Results AvailableHeart FailureBehavioral: Education by community pharmacisthttps://ClinicalTrials.gov/show/NCT00211289
179033179033A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's LymphomaCompletedNo Results AvailableLymphoma, B-CellDrug: ONTAK (denileukin diftitox)https://ClinicalTrials.gov/show/NCT00211276
179034179034Bipolar Disorder Research Study for Ages 12 and OlderCompletedNo Results AvailableBipolar DisorderBehavioral: Enhanced Clinical Intervention|Drug: mood stabilizerhttps://ClinicalTrials.gov/show/NCT00211263
179035179035Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ERCompletedNo Results AvailableMood DisorderDrug: Valproic Acid and Depakote ERhttps://ClinicalTrials.gov/show/NCT00211250
179036179036CAFE Study - Cancer Patient Fracture EvaluationCompletedHas ResultsCancer|Spinal FracturesDevice: Balloon Kyphoplasty|Other: Non Surgical Managementhttps://ClinicalTrials.gov/show/NCT00211237
179037179037Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)TerminatedNo Results AvailableMultiple System Atrophy|Progressive Supranuclear PalsyDrug: Riluzolehttps://ClinicalTrials.gov/show/NCT00211224
179038179038FREE Study - Fracture Reduction EvaluationCompletedNo Results AvailableOsteopenia|Osteoporosis|Multiple Myeloma|Bone NeoplasmsDevice: Balloon Kyphoplastyhttps://ClinicalTrials.gov/show/NCT00211211
179039179039Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)CompletedNo Results AvailableLymphoma, T-Cell, CutaneousDrug: ONTAK (denileukin difitox, DAB389IL-2)https://ClinicalTrials.gov/show/NCT00211198
179040179040A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell LymphomaActive, not recruitingNo Results AvailableLymphoma, T-Cell, PeripheralDrug: ONTAK (denileukin diftitox, DAB389 IL-2)https://ClinicalTrials.gov/show/NCT00211185

* Görseller ve İçerik tekif hakkına sahip olabilir